WNK2 and Langerhans cell histiocytosis: Gene mutations in LCH have been observed in the RAS - RAF - MAP2K (mitogen-activated protein kinase kinase) - MAPK (mitogen-activated protein kinase) signal pathway, including BRAFV600E or MAP2K1 mutations [14–16].